NRG3 gene is associated with the risk and age at onset of Alzheimer disease

Journal of Neural Transmission

Volumn 121, Issue 2, 2014, Pages 183-192

  Wang, Ke Sheng ^a   Xu, Nuo ^a   Wang, Liang ^a   Aragon, Lorenzo ^b   Ciubuc, Radu ^b   Arana, Tania Bedard ^c   Mao, Chunxiang ^d   Petty, Leonora ^c   Briones, David ^c   Su, Brenda Bin ^e   Luo, Xingguang ^f   Camarillo, Cynthia ^c   Escamilla, Michael A ^c   Xu, Chun ^c  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b Paul L Foster School of Medicine   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e HARBIN MEDICAL UNIVERSITY   (China)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age at onset; Alzheimer disease; NRG3 gene; Single nucleotide polymorphisms

Indexed keywords

MICRORNA; NEU DIFFERENTIATION FACTOR; NEU DIFFERENTIATION FACTOR 3; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NEUREGULINS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS;

EID: 84893470521     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1091-0     Document Type: Article

References (45)

1. Alzheimer's-Association, Thies W, Bleiler L (2011) Alzheimer's disease facts and figures. Alzheimer's Dement 7(2):208-244. doi: 10.1016/j.jalz.2011.02. 004
2. Anton ES, Ghashghaei HT, Weber JL, McCann C, Fischer TM, Cheung ID, Lai C (2004) Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat Neurosci 7(12):1319-1328. doi: 10.1038/nn1345
3. Assimacopoulos S, Grove EA, Ragsdale CW (2003) Identification of a Pax6-dependent epidermal growth factor family signaling source at the lateral edge of the embryonic cerebral cortex. J Neurosci 23(16):6399-6403
4. Avramopoulos D, Wang R, Valle D, Fallin MD, Bassett SS (2007) A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease. Neurogenetics 8(2):111-120. doi: 10.1007/s10048-007-0081-5
5. Balciuniene J, Feng N, Iyadurai K, Hirsch B, Charnas L, Bill BR, Selleck SB (2007) Recurrent 10q22-q23 deletions: a genomic disorder on 10q associated with cognitive and behavioral abnormalities. Am J Hum Genet 80(5):938-947. doi: 10.1086/513607
6. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265. doi: 10.1093/bioinformatics/bth457
7. Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, Graff-Radford NR (2009) Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat Genet 41(2):192-198. doi: 10.1038/ng.305
8. Carteron C, Ferrer-Montiel A, Cabedo H (2006) Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival. J Cell Sci 119(Pt 5):898-909. doi: 10.1242/jcs.02799
9. Donix M, Small GW, Bookheimer SY (2012) Family history and APOE-4 genetic risk in Alzheimer's disease. Neuropsychol Rev 22(3):298-309. doi: 10.1007/s11065-012-9193-2
10. Dudbridge F (2008) Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66(2):87-98. doi: 10.1159/000119108
11. Fallin MD, Lasseter VK, Wolyniec PS, McGrath JA, Nestadt G, Valle D, Pulver AE (2003) Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am J Hum Genet 73(3):601-611. doi: 10.1086/378158
12. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278(16):1349-1356
13. Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, Guzman D, Matthews PM (2009) Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease. Neuroimage 44(3):724-728. doi: 10.1016/j.neuroimage.2008.10.003
14. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296(5576):2225-2229. doi: 10.1126/science.1069424
15. Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Pedersen NL (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63(2):168-174. doi: 10.1001/archpsyc.63.2.168
16. Harrison PJ, Tunbridge EM (2008) Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 33(13):3037-3045. doi: 10.1038/sj.npp.1301543
17. Heinzen EL, Need AC, Hayden KM, Chiba-Falek O, Roses AD, Strittmatter WJ, Goldstein DB (2010) Genome-wide scan of copy number variation in late-onset Alzheimer's disease. J Alzheimers Dis 19(1):69-77. doi: 10.3233/JAD-2010-1212
18. Hollingworth P, Harold D, Jones L, Owen MJ, Williams J (2011) Alzheimer's disease genetics: current knowledge and future challenges. Int J Geriatr Psychiatry 26(8):793-802. doi: 10.1002/gps.2628
19. Hollingworth P, Sweet R, Sims R, Harold D, Russo G, Abraham R, Williams J (2012) Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry 17(12):1316-1327. doi: 10.1038/mp.2011.125
20. Ivleva EI, Morris DW, Moates AF, Suppes T, Thaker GK, Tamminga CA (2010) Genetics and intermediate phenotypes of the schizophrenia - bipolar disorder boundary. Neurosci Biobehav Rev 34(6):897-921. doi: 10.1016/j.neubiorev.2009.11. 022
21. Kao WT, Wang Y, Kleinman JE, Lipska BK, Hyde TM, Weinberger DR, Law AJ (2010) Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc Natl Acad Sci USA 107(35):15619-15624. doi: 10.1073/pnas.1005410107
22. Lambert JC, Amouyel P (2011) Genetics of Alzheimer's disease: new evidences for an old hypothesis? Curr Opin Genet Dev 21(3):295-301. doi: 10.1016/j.gde.2011.02.002
23. Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R (2008) Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. Arch Neurol 65(11):1518-1526. doi: 10.1001/archneur.65.11.1518
24. Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, Roses AD (2008) Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 65(1):45-53. doi: 10.1001/archneurol.2007.3
25. Liu F, Arias-Vasquez A, Sleegers K, Aulchenko YS, Kayser M, Sanchez-Juan P, van Duijn CM (2007) A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population. Am J Hum Genet 81(1):17-31. doi: 10.1086/518720
26. Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, Nazareth L, Gibbs RA (2010) Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 362(13):1181-1191. doi: 10.1056/NEJMoa0908094
27. Lutz MW, Crenshaw DG, Saunders AM, Roses AD (2010) Genetic variation at a single locus and age of onset for Alzheimer's disease. Alzheimer's Dement J Alzheimer's Assoc 6(2):125-131. doi: 10.1016/j.jalz.2010.01.011
28. Marchini J, Cardon LR, Phillips MS, Donnelly P (2004) The effects of human population structure on large genetic association studies. Nat Genet 36(5):512-517. doi: 10.1038/ng1337
29. Meier S, Strohmaier J, Breuer R, Mattheisen M, Degenhardt F, Mühleisen TW, Schulze TG, Nöthen MM, Cichon S, Rietschel M, Wüst S (2013) Neuregulin 3 is associated with attention deficits in schizophrenia and bipolar disorder. Int J Neuropsychopharmacol 16(3):549-556. doi: 10.1017/S1461145712000697
30. Morar B, Dragovic M, Waters FA, Chandler D, Kalaydjieva L, Jablensky A (2011) Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition. Mol Psychiatry 16(8):860-866. doi: 10.1038/mp.2010.70
31. Piacentini S, Polimanti R, Squitti R, Mariani S, Migliore S, Vernieri F, Fuciarelli M (2012) GSTO1 E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: association hypothesis for an uncommon genetic variant. Neurosci Lett 506(2):203-207. doi: 10.1016/j.neulet.2011.11.005
32. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559-575. doi: 10.1086/519795
33. Reisberg H, Ferris SH, Sclan SG (1993) Empirical evaluation of the global deterioration scale for staging Alzheimer's disease. Am J Psychiatry 150(4):680-682
34. Reitz C, Cheng R, Schupf N, Lee JH, Mehta PD, Rogaeva E, Mayeux R (2012) Association between variants in IDE-KIF11-HHEX and plasma amyloid beta levels. Neurobiol Aging 33(1):199 e113-199 e197. doi: 10.1016/j.neurobiolaging.2010.07. 005
35. Rogers BS, Lippa CF (2012) A clinical approach to early-onset inheritable dementia. Am J Alzheimers Dis Other Demen 27(3):154-161. doi: 10.1177/1533317512444000
36. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Roses AD (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90(20):9649-9653
37. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, Haussler D (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15(8):1034-1050. doi: 10.1101/gr.3715005
38. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90(5):1977-1981
39. Sweet RA, Nimgaonkar VL, Devlin B, Lopez OL, DeKosky ST (2002) Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology 58(6):907-911
40. Sweet RA, Bennett DA, Graff-Radford NR, Mayeux R, National Institute on Aging Late-Onset Alzheimer's Disease Family Study, Group (2010) Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. Brain 133(Pt 4):1155-1162. doi: 10.1093/brain/awq001
41. Thompson PM, Mega MS, Woods RP, Zoumalan CI, Lindshield CJ, Blanton RE, Toga AW (2001) Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex 11(1):1-16
42. Twine NA, Janitz K, Wilkins MR, Janitz M (2011) Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease. PLoS One 6(1):e16266. doi: 10.1371/journal. pone.0016266
43. Uhlhaas PJ, Singer W (2006) Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron 52(1):155-168. doi: 10.1016/j.neuron.2006.09.020
44. Wu L, Rosa-Neto P, Hsiung GY, Sadovnick AD, Masellis M, Black SE, Gauthier S (2012) Early-onset familial Alzheimer's disease (EOFAD). Can J Neurol Sci 39(4):436-445
45. Zhang D, Sliwkowski MX, Mark M, Frantz G, Akita R, Sun Y, Godowski PJ (1997) Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci USA 94(18):9562-9567